Delivery Order 36F79718D0355-36C25019F0648
Award Date 1/23/19
Potential Completion Date 4/30/19
Potential Value $60K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Frisco, TX 75034, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The NIH Clinical Center awarded a purchase order to ASD Specialty Healthcare, LLC for $13,895.94 on January 28, 2019, for Soliris (eculizumab 10 mg/mL injection solution), a specialty pharmaceutical product. Performance is located in Frisco, Texas. The order is firm fixed price with no set-aside designation. Ultimate completion is scheduled for February 27, 2019.</p>
- The Defense Logistics Agency awarded a $19,873 delivery order to DMS Pharmaceutical Group Inc. to supply 4561806823 SOLIRIS 300 MG/30 ML VIAL 30ML. The firm fixed price order is being funded by the Defense Logistics Agency and will be performed in Park Ridge, Illinois with work scheduled to be completed by August 29, 2023. SOLIRIS is a therapeutic medication used to treat certain rare diseases. This small order for SOLIRIS vials supports the Defense Logistics Agency's mission to provide...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency Troop Support Medical (DLA) to DMS Pharmaceutical Group Inc. for the supply of 4562177887 SOLIRIS 300 MG/30 ML VIAL 30ML. The contract value is $39,746 and requires delivery to a location in Park Ridge, Illinois between September 11 and October 2, 2023. DLA supports the medical readiness of armed forces through procurement and distribution of pharmaceuticals, medical supplies, and equipment. SOLIRIS is a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $40,058.24 firm-fixed-price contract is for the delivery of Soliris (300 mg/30 ml vial) with a completion date of March 5, 2024. DMS Pharmaceutical Group Inc. holds a separate $4,999,999 indefinite delivery contract (4600082013) with the DLA under the SPE2DB program, which enables the agency to issue...
- <p>The Defense Logistics Agency issued a $59,072.02 delivery order to Amerisourcebergen Drug Corp on May 27, 2026, for Ultomiris 1,100 mg/11 ml vials. The order is firm fixed-price with an ultimate completion date of June 17, 2026. Place of performance is Conshohocken, PA. No parent vehicle is named in the source.</p>
- The Defense Logistics Agency Troop Support Medical awarded a $79,492 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 4562162778 SOLIRIS 300 MG/30 ML VIAL 30ML. The place of performance is Park Ridge, Illinois and the period of performance is September 11, 2023 through October 2, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency supports Department of Defense health care programs by procuring pharmaceuticals, medical...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on April 13, 2026, for Ultomiris (pecirilumab) 300 mg/3 mL vials, with a ceiling value of $56,503.48 under firm fixed-price terms. Place of performance is Conshohocken, PA. The order has an ultimate completion date of May 4, 2026. No set-aside was applied. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at up...
- <p>The Defense Logistics Agency issued a $59,072.02 delivery order to Amerisourcebergen Drug Corp on May 20, 2026, for Ultomiris 1,100 mg/11 ml vials.</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed-price structure with an ultimate completion date of June 11, 2026. No set-aside was used. The order is issued under a DLA Troop Support Medical indefinite delivery contract supporting pharmaceutical supply to Defense Health Agency and military medical facilities.</p>
- The Defense Logistics Agency issued a $28,251.81 delivery order to Amerisourcebergen Drug Corp on April 29, 2026, for Ultomiris (periphreral) 1,100 mg/11 ml vial pharmaceutical supply. Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure and an ultimate completion date of May 20, 2026. No set-aside was used. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc. and serves as the execution entity for DLA pharmaceutical distribution, competing on...
- This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $80,272.48, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) for Soliris 300 mg/30 ml vials. Soliris is a specialized pharmaceutical product used for medical treatment. The contract is not associated with any set-aside designation, which allows DMS Pharmaceutical Group to leverage its...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79718D0355Federal Supply Schedule
- 36F79718D0355-36C25019F0648Delivery Order
12 VIALS ECULAZUMAB (SOLIRIS) INJ. 10MG/ML
Posted 1/23/19
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Roxane Laboratories, Inc. 900 Ridgebury Road Ridgefield, CT 06877 | 65IB | Department of Veterans Affairs National Acquisition Center | Award Notice 1/1 | 8/12/16, 2:39 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Change Order | $953 | 3/27/19 | |
| Not listed | Not listed | $58.8k | 1/23/19 |